Halozyme Therapeutics (HALO) Selling, General & Administrative (2010 - 2026)
Halozyme Therapeutics' Selling, General & Administrative came in at $57 million for Q2 2026, up 37.0% from $41.61 million a year earlier but down 1.5% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Halozyme Therapeutics reported Selling, General & Administrative of $238 million, up 42.1% year-over-year; for FY2025, it was $207.09 million, up 34.2% from FY2024.
- Selling, General & Administrative has increased in each of the last five years, with a five-year compound annual growth rate of 35.3% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $154.34 million in FY2024 (+3.5%), $149.18 million in FY2023 (+3.9%), $143.53 million in FY2022 (+185.2%) and $50.32 million in FY2021 (+10.0%).
- The five-year range for quarterly Selling, General & Administrative is $13.17 million (Q3 2021) to $77.03 million (Q4 2025).
- Year-over-year, Selling, General & Administrative has increased for eight consecutive quarters, with growth averaging 29.3% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q2 2022 (growth of 366.5%), and the weakest in Q2 2023 (a decline of 32.2%).
- Business Quant data shows HALO's Selling, General & Administrative at $57.88 million (Q1 2026), $77.03 million (Q4 2025) and $46.09 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn | 57.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.00 Mn |
| Mar 31, 2026 | 57.88 Mn |
| Dec 31, 2025 | 77.03 Mn |
| Sep 30, 2025 | 46.09 Mn |
| Jun 30, 2025 | 41.61 Mn |
| Mar 31, 2025 | 42.36 Mn |
| Dec 31, 2024 | 42.25 Mn |
| Sep 30, 2024 | 41.24 Mn |
| Jun 30, 2024 | 35.71 Mn |
| Mar 31, 2024 | 35.13 Mn |
| Dec 31, 2023 | 37.61 Mn |
| Sep 30, 2023 | 35.27 Mn |
| Jun 30, 2023 | 38.95 Mn |
| Mar 31, 2023 | 37.36 Mn |
| Dec 31, 2022 | 37.75 Mn |
| Sep 30, 2022 | 34.47 Mn |
| Jun 30, 2022 | 57.48 Mn |
| Mar 31, 2022 | 13.83 Mn |
| Dec 31, 2021 | 13.77 Mn |
| Sep 30, 2021 | 13.17 Mn |
API Access
Halozyme Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();